2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.

This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. Keeping that in mind, here are two large-cap stocks whose competitive advantages create flywheel effects and one whose existing offerings may be tapped out.

One Large-Cap Stock to Sell:

Gilead Sciences (GILD)

Market Cap: $165.9 billion

From its groundbreaking work in developing the first single-tablet regimens for HIV treatment, Gilead Sciences (NASDAQ:GILD) develops and markets innovative medicines for life-threatening diseases including HIV, viral hepatitis, COVID-19, and cancer.

Why Is GILD Not Exciting?

1. Scale is a double-edged sword because it limits the company’s growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 3.6% for the last five years
2. 7.5 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position
3. Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability

At $133.29 per share, Gilead Sciences trades at 15.5x forward P/E. If you’re considering GILD for your portfolio, see our FREE research report to learn more.

Two Large-Cap Stocks to Watch:

Fastenal (FAST)

Market Cap: $52.18 billion

Founded in 1967, Fastenal (NASDAQ:FAST) provides industrial and construction supplies, including fasteners, tools, safety products, and many other product categories to businesses globally.

Why Do We Watch FAST?

1. Average unit sales growth of 9.1% over the past two years reflects steady demand for its products
2. Offerings are mission-critical for businesses and lead to a best-in-class gross margin of 45.5%
3. Excellent operating margin of 20.4% highlights the efficiency of its business model

Fastenal’s stock price of $45.35 implies a valuation ratio of 35.1x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.

Arthur J. Gallagher (AJG)

Market Cap: $56.35 billion

Founded in 1927 and operating in approximately 130 countries through direct operations and correspondent networks, Arthur J. Gallagher (NYSE:AJG) provides insurance brokerage, reinsurance, consulting, and third-party claims settlement services to businesses and individuals worldwide.

Why Is AJG a Good Business?

1. Impressive 17.9% annual revenue growth over the last two years indicates it’s winning market share this cycle
2. Earnings per share grew by 17.7% annually over the last five years and trumped its peers
3. Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends

Arthur J. Gallagher is trading at $219.63 per share, or 16.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.